MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirigiti, P.
Right arrow Articles by Machida, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirigiti, P.
Right arrow Articles by Machida, C. A.

Vol. 60, Issue 6, 1308-1324, December 2001

Agonist-Mediated Down-Regulation of Rat beta 1-Adrenergic Receptor Transcripts: Role of Potential Post-Transcriptional Degradation Factors

Philbert Kirigiti, Ying Bai, Yong-Feng Yang, Xiaorong Li,1 Biao Li,2 Gary Brewer, and Curtis A. Machida

Division of Neuroscience, Oregon Regional Primate Research Center, Oregon Health & Science University West Campus, Beaverton, Oregon (P.K., Y.B., Y.-F.Y., X.L., B.L., C.A.M.); Department of Molecular Genetics and Microbiology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey (G.B.); Department of Biochemistry and Molecular Biology and Graduate Program in Neuroscience, Oregon Health & Science University, Portland, Oregon (C.A.M.)

The human beta 1-adrenergic receptor (AR) and hamster beta 2-AR transcripts can be post-transcriptionally regulated at the level of mRNA stability and undergo accelerated agonist-mediated degradation via interaction of their 3' untranslated regions (UTR) with RNA binding proteins. Using RNase protection assays, we have determined that chronic isoproterenol exposure of rat C6 glioma cells results in the accelerated reduction of beta 1-AR mRNAs. To determine the role of cellular environment on the agonist-independent and agonist-mediated degradation of beta 1-AR mRNAs, we transfected rat beta 1-AR expression recombinants into both hamster DDT1MF2 cells and rat L6 cells. The rat beta 1-AR mRNAs in the two transfectant cell pools retain longer agonist-independent half-lives than in the C6 environment and undergo accelerated degradation upon chronic agonist exposure. Using UV-cross-linking/immunoblot and immunoprecipitation analyses, we have determined that the rat beta 1-AR 3' UTR recognizes a predominant Mr 39,000 component, identified as the mammalian elav-like protein HuR, and several other minor components, including the heteronuclear protein hnRNP A1. HuR levels are more highly expressed in C6 cells than in DDT1MF2 and L6 cells and are induced after chronic isoproterenol treatment. Furthermore, C6 transfectants containing an HuR expression recombinant exhibit reduced beta 1-AR mRNA half-lives that were statistically comparable with half-lives identified in isoproterenol-treated C6 cells. These results imply that HuR plays a potential role in the agonist-independent and agonist-mediated down-regulation of beta 1-AR mRNAs.


1 Current address: Department of Medical and Molecular Genetics, Oregon Health & Science, University, Portland, Oregon.

2 Current address: Center for Human Molecular Genetics, Munroe-Meyer Institute, University of Nebraska Medical College, Omaha, Nebraska.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Cherry, H. Jones, V. A. Karschner, and P. H. Pekala
Post-transcriptional Control of CCAAT/Enhancer-binding Protein {beta} (C/EBP{beta}) Expression: FORMATION OF A NUCLEAR HuR-C/EBP{beta} mRNA COMPLEX DETERMINES THE AMOUNT OF MESSAGE REACHING THE CYTOSOL
J. Biol. Chem., November 7, 2008; 283(45): 30812 - 30820.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Pullmann Jr., M. Juhaszova, I. L. de Silanes, T. Kawai, K. Mazan-Mamczarz, M. K. Halushka, and M. Gorospe
Enhanced Proliferation of Cultured Human Vascular Smooth Muscle Cells Linked to Increased Function of RNA-binding Protein HuR
J. Biol. Chem., June 17, 2005; 280(24): 22819 - 22826.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kandasamy, K. Joseph, K. Subramaniam, J. R. Raymond, and B. G. Tholanikunnel
Translational Control of {beta}2-Adrenergic Receptor mRNA by T-cell-restricted Intracellular Antigen-related Protein
J. Biol. Chem., January 21, 2005; 280(3): 1931 - 1943.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Gardner, N. M. D. Santos, S. G. Matta, M. A. Whitt, and S. W. Bahouth
Role of the Cyclic AMP-dependent Protein Kinase in Homologous Resensitization of the {beta}1-Adrenergic Receptor
J. Biol. Chem., May 14, 2004; 279(20): 21135 - 21143.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. A. Michelotti, M. J. Bauman, M. P. Smith, and D. A. Schwinn
Cloning and Characterization of the Rat alpha 1a-Adrenergic Receptor Gene Promoter. DEMONSTRATION OF CELL SPECIFICITY AND REGULATION BY HYPOXIA
J. Biol. Chem., February 28, 2003; 278(10): 8693 - 8705.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics